EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis

Xiaotian Chen, Mingming Zhang, Fan Zhou, Zhengrong Gu, Yuan Li, Ting Yu, Chunyan Peng, Lixing Zhou, Xiangrui Li, Dandan Zhu, Xiaoqi Zhang, Chenggong Yu iD

Inflammatory Bowel Diseases · 05.12.2023 · 29 (12) · 1929-1940

DOI: 10.1093/ibd/izad099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 19.06.2023. Verfasst von Xiaotian Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing 210008, P.R. China. Hauptthemen laut MEDLINE: Sirtuin 3, Colitis, Colitis, Ulcerative. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Honokiol (HKL), a natural extract of the bark of the magnolia tree and an activator of the mitochondrial protein sirtuin-3 (SIRT3), has been proposed to possess anti-inflammatory effects. This study investigated the inhibitory effects of HKL on T helper (Th) 17 cell differentiation in colitis.

Methods

Serum and biopsies from 20 participants with ulcerative colitis (UC) and 18 healthy volunteers were collected for the test of serum cytokines, flow cytometry analysis (FACS), and relative messenger RNA (mRNA) levels of T cell subsets, as well as the expression of SIRT3 and phosphorylated signal transducer and activator of transcription/retinoic acid-related orphan nuclear receptor γt (p-STAT3/RORγt) signal pathway in colon tissues. In vitro, naïve clusters of differentiation (CD) 4 + T cells isolated from the mouse spleen differentiated to subsets including Th1, Th2, Th17, and regulatory T (Treg) cells. Peripheral blood monocytes (PBMCs) from healthy volunteers were induced to the polarization of Th17 cells. After HKL treatment, changes in T cell subsets, related cytokines, and transcription factors were measured. The dextran sulfate sodium (DSS)-induced colitis and interleukin (IL)-10-deficient mice were intraperitoneally injected with HKL. These experiments were conducted to study the effect of HKL on the development, cytokines, and expression of signaling pathway proteins in colitis.

Results

Patients with UC had higher serum IL-17 and a higher proportion of Th17 differentiation in blood compared with healthy participants; while IL-10 level and the proportion of Treg cells were lower. Higher relative mRNA levels of RORγt and a lower SIRT3 expression in colon tissues were observed. In vitro, HKL had little effect on the differentiation of naïve CD4+ T cells to Th1, Th2, or Treg cells, but it downregulated IL-17 levels and the Th17 cell ratio in CD4+ T cells from the mouse spleen and human PBMCs under Th17 polarization. Even with a STAT3 activator, HKL still significantly inhibited IL-17 levels. In DSS–induced colitis mice and IL-10 deficient mice treated with HKL, the length of the colon, weight loss, disease activity index, and histopathological scores were improved, IL-17 and IL-21 levels, and the proportion of Th17 cells were decreased. Sirtuin-3 expression was increased, whereas STAT3 phosphorylation and RORγt expression were inhibited in the colon tissue of mice after HKL treatment.

Conclusions

Our study demonstrated that HKL could partially protect against colitis by regulating Th17 differentiation through activating SIRT3, leading to inhibition of the STAT3/RORγt signaling pathway. These results provide new insights into the protective effects of HKL against colitis and may facilitate the research of new drugs for inflammatory bowel disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 3ColitisColitis, UlcerativeHumansAnimalsMiceInterleukin-17Interleukin-10Nuclear Receptor Subfamily 1, Group F, Member 3Th17 CellsT-Lymphocytes, RegulatoryCytokinesCell DifferentiationRNA, MessengerDextran SulfateAllyl CompoundsBiphenyl CompoundsPhenols

Stichwörter der Autor:innen

T helper 17 cellshonokiolmitochondrial deacetylase Sirt3signal transduction and activator of transcription 3ulcerative colitis

Substanzen

Interleukin-17Interleukin-10Nuclear Receptor Subfamily 1, Group F, Member 3Sirtuin 3CytokinesRNA, MessengerDextran SulfatehonokiolAllyl CompoundsBiphenyl Compounds

Autor:innen und Institutionen

  • Department of Clinical Nutrition, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing 210008, P.R. China.
  • Department of Gastroenterology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing 210008, P.R. China.
  • Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, State Key Laboratory for Oncogenes and Related Genes, Key Laborato…
  • Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, P.R. China.
  • Department of Gastroenterology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210017, P.R. China.
  • Department of Gastroenterology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China.

ORCID-Profile: Chenggong Yu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, X., Zhang, M., Zhou, F., Gu, Z., Li, Y., Yu, T., Peng, C., Zhou, L., Li, X., Zhu, D., Zhang, X., & Yu, C. (2023). SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis. Inflammatory Bowel Diseases, 29(12), 1929-1940. https://doi.org/10.1093/ibd/izad099

Vancouver

Chen X, Zhang M, Zhou F, Gu Z, Li Y, Yu T, et al. SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis. Inflammatory Bowel Diseases. 2023;29(12):1929-1940. doi:10.1093/ibd/izad099

BibTeX
@article{Chen2023,
  author = {Chen, Xiaotian and Zhang, Mingming and Zhou, Fan and Gu, Zhengrong and Li, Yuan and Yu, Ting and Peng, Chunyan and Zhou, Lixing and Li, Xiangrui and Zhu, Dandan and Zhang, Xiaoqi and Yu, Chenggong},
  title = {SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis},
  journal = {Inflammatory Bowel Diseases},
  year = {2023},
  volume = {29},
  number = {12},
  pages = {1929--1940},
  doi = {10.1093/ibd/izad099}
}
Kostenlos starten →